Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tumor")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 808886

  • Page / 32356

Export

Selection :

  • and

Polyamines in relation to human breast, rectal and sopramous cell carcinomaRATNA CHANDA; GANGULY, A. K.Cancer letters. 1988, Vol 39, Num 3, pp 311-318, issn 0304-3835Article

The clinical value of tissue polypeptide antigen (TPA): a reviewLÜTHGENS, M; SCHIEGEL, G.Journal of tumor marker oncology. 1987, Vol 2, Num 4, pp 261-271, issn 0886-3849Article

The clinical usefulness and limitations of tumor markersTOROSIAN, M. H.Surgery, gynecology & obstetrics. 1988, Vol 166, Num 6, pp 567-579, issn 0039-6087Article

Intérêt du dosage des marqueurs tumoraux = Lesefulness of tumoral markers assayROUX, F; BISSET, J. P.Méditerranée médicale. 1988, Num 379, pp 39-40, issn 0302-9263Conference Paper

Remarques, critiques sur la signification des marqueurs tumoraux = About the signification of tumoral markersSTEFFEN, A.Lyon Méditerranée médical. Médecine du sud-est. 1989, Vol 25, Num 5-6, issn 0766-5466, 12329-12334 [4 p.]Article

KP1 (CD68) staining of granular cell neoplasms : is KP1 a marker for lysosomes rather than the histiocytic lineage ?TSANG, W. Y. M; CHAN, J. K. C.Histopathology. 1992, Vol 21, Num 1, pp 84-86, issn 0309-0167Article

Expression of pancreatic secretory trypsin inhibitor in various cancer cellsOGAWA, M; MATSUURA, N; HIGASHIYAMA, K et al.Research communications in chemical pathology and pharmacology. 1987, Vol 55, Num 1, pp 137-140, issn 0034-5164Article

The biological characteristics of chromogranin a and its role as a circulating marker in neuroendocrine tumoursFERRARI, L; SEREGNI, E; BAJETTA, E et al.Anticancer research. 1999, Vol 19, Num 4C, pp 3415-3427, issn 0250-7005Article

Tumor necrosis factor-α promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IXAIDOO, Michael; MCELROY, Peter D; KOLCZAK, Margarette S et al.Genetic epidemiology. 2001, Vol 21, Num 3, pp 201-211, issn 0741-0395Article

Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancersHIRABAYASHI, Y; KASAKURA, H; MATSUMOTO, M et al.Japanese journal of cancer research. 1987, Vol 78, Num 3, pp 251-260, issn 0910-5050Article

Adenomatoid tumor of ejaculatory ductKANG FAN; JOHNSON, D. F.Urology (Ridgewood, NJ). 1985, Vol 25, Num 6, pp 653-654, issn 0090-4295Article

Many different tumor types have polyclonal tumor origin : Evidence and implicationsPARSONS, Barbara L.Mutation research. Reviews in mutation research. 2008, Vol 659, Num 3, pp 232-247, issn 1383-5742, 16 p.Article

A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3LYUBSKY, S; MADARIAGA, J; LOZOWSKI, M et al.American journal of clinical pathology. 1988, Vol 89, Num 2, pp 160-167, issn 0002-9173Article

Tumor markersScandinavian journal of clinical & laboratory investigation. Supplement. 1988, Vol 48, pp 35-49, issn 0085-591X, suppl. 190Conference Paper

Les marqueurs du cancer du sein = Breast cancer markersESPIE, M.Gazette médicale de France (1969). 1990, Vol 97, Num 20, pp 14-15, issn 0016-5557Article

Investigation of expression of 5T4 antigen in cervical cancerJONES, H; ROBERTS, G; HOLE, N et al.British journal of cancer. 1990, Vol 61, Num 1, pp 96-100, issn 0007-0920Article

Clinical experience with CA-50 in the serum of carcinoma patientsHABIB, N. A; HERSHMAN, M. J; KELLY, S. B et al.European journal of surgical oncology. 1989, Vol 15, Num 4, pp 361-366, issn 0748-7983Article

Tumour marker immunoreactivity in adenocarcinomaELLIS, I. O; HITCHCOCK, A.Journal of clinical pathology. 1988, Vol 41, Num 10, pp 1064-1067, issn 0021-9746Article

Mise au point sur les marqueurs tumoraux = Tumoral markersCATIMAL, G; PASQUIER, J; BACHET, P et al.Journal de médecine de Lyon (Lyon. 1864). 1989, Vol 70, Num 1443, pp 11-15, issn 0021-7883Article

Elevated activities of serum α(1→3)-L-fucosyltransferase in human cancerYAZAWA, S; ASAO, T; NAGAMACHI, Y et al.Journal of tumor marker oncology. 1989, Vol 4, Num 4, pp 355-362, issn 0886-3849Article

Les marqueurs tumoraux = Tumor markersBOURGUET, P; KERBRAT, P; GEDOUIN, D et al.L' Eurobiologiste (Paris). 1990, Num 185, pp 5-10, issn 0999-5749, 6 p.Article

Tumor markers in small cell lung cancerHANSEN, H. H; HANSEN, M.European journal of cancer & clinical oncology. 1987, Vol 23, Num 11, pp 1585-1587, issn 0277-5379Article

Intérêt des marqueurs tumoraux dans la surveillance des cancers = Value of tumoral markers in cancer follow upKLEISBAUER, J. P.Méditerranée médicale. 1987, Num 371, pp 31-32, issn 0302-9263Conference Paper

Clinical application of four tumor markers in monitoring of cancer patientsCHIA, D; TERASAKI, P; ROSENBLOOM, B et al.Journal of tumor marker oncology. 1989, Vol 4, Num 4, pp 349-353, issn 0886-3849Article

Pattern recognition in clinical chemistry: tumor markersLANTERI, S; CONTI, P; BERBELLINI, A et al.Journal of chemometrics. 1988, Vol 3, pp 293-299, issn 0886-9383, suppl. AArticle

  • Page / 32356